Results 181 to 190 of about 40,027 (305)

Serum Kynurenine Pathway Metabolites as Candidate Diagnostic Biomarkers for Pituitary Adenoma: A Case-Control Study. [PDF]

Medicina (Kaunas)
Oflas ND, Akbay Hİ, Alay M, Erdem M.
europepmc   +1 more source

Molecular cloning of rat kynurenine aminotransferase: Identity with glutamine transaminase K [PDF]

, 1994
Monica Mosca, Liviana Cozzi, Jérôme Breton, Carmela Speciale, Etsuo Okuno, Robert M. Schwarcz, Luca Benatti   +6 more
openalex   +1 more source

Krüppel‐Like Factor 4, a Hub Gate for Cell Crosstalk in Tumor Microenvironment

Cancer Medicine, Volume 15, Issue 1, January 2026.
Krüppel‐like factor 4 (KLF4) exhibits a dual, context‐dependent role, acting as both a tumor suppressor and an oncogene. It remodels the tumor microenvironment by modulating cancer, stromal, and immune cells, representing a promising yet complex therapeutic target for cancer treatment.
Min Tang, Binle Tian, Jingyi Zhou, Di Ma, Rongze Sun, Qi Li   +5 more
wiley   +1 more source

Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Our multiomics analysis across three PD cohorts revealed distinct fecal microbiome and plasma metabolome alterations in patients with motor complications (PD‐MC). We identified specific microbial and metabolic biomarkers and uncovered significant correlations between them, providing new insights into PD‐MC pathophysiology. ABSTRACT Background Parkinson'
Shuangjie Qian, Jialong Hou, Xi Xiong, Qi Duan, Tao Jiang, Yi Zheng, Weiwei Quan, Jiaxue Xu, Keke Chen, Jingjing Qian, Hongchang Gao, Chenglong Xie   +11 more
wiley   +1 more source

KYNURENINE TRANSAMINASE FROM NEUROSPORA

Journal of Biological Chemistry, 1956
D M, BONNER, W B, JAKOBY
openaire   +2 more sources

Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Overview of study design. Metagenomic and plasma/fecal metabolomic studies were performed in 44 NSCLC patients who underwent neoadjuvant tislelizumab therapy plus platinum ‐ based doublet chemotherapy. Abstract Background Neoadjuvant anti‐programmed cell death 1 (PD‐1) immunochemotherapy has shown promising efficiency in the treatment of early‐stage ...
Ailing Cao, Yaobin Lin, Shaoxing Guan, Youhao Chen, Wenyu Zhai, Yuheng Zhou, Shoucheng Feng, Yanping Guan, Yiyu Zhang, Min Huang, Xueding Wang, Hao Long   +11 more
wiley   +1 more source

Kynurenine Pathway Dysregulation in Parkinson's Disease: Insights for Disease Modulation and Therapy. [PDF]

Int J Tryptophan Res
Chakkarwar VA, Kulkarni YA.
europepmc   +1 more source

Kynurenine Formamidase and Tetrahydrofolic Acid. [PDF]

, 1968
Risto Santti, Juhani T. Soini, Gunilla Carlsson, Olav Smidsrød   +3 more
openalex   +1 more source

Genomic imprinting in an early‐diverging angiosperm reveals an ancient mechanism for seed initiation in flowering plants

New Phytologist, Volume 249, Issue 4, Page 1580-1591, February 2026.
Ana M. Florez‐Rueda, Mathias Scharmann, Leonardo P. de Souza, Alisdair R. Fernie, Julien B. Bachelier, Duarte D. Figueiredo   +5 more
wiley   +1 more source

Restoring Immunological Tolerance via Dendritic Cells in Rheumatoid Arthritis

European Journal of Immunology, Volume 56, Issue 1, January 2026.
This review examines the failure of peripheral immune tolerance as the initiating factor in rheumatoid arthritis (RA), focusing on the role of dendritic cells. It discusses strategies to convert these cells from immunogenic to tolerogenic states, while also exploring emerging research on the anatomical sites where this critical loss of tolerance occurs.
Hannah Costello, Andrea Woodcock, Mary Canavan   +2 more
wiley   +1 more source